Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)
Document type:
Meeting Abstract
Author(s):
Griesinger, F.; Sebastian, M.; Brueckl, W.; Hummel, H-D.; Jaeschke, B.; Kern, J.; Schumann, C.; Wesseler, C.; Jaenicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Groth, A.; Weichert, W.; Doerfel, S.; Petersen, V.; Schroeder, J.; Wilke, J.; Eberhardt, W. E. E.; Thomas, M.